Abstract YO16
Case summary
A 16-year-old female with no known comorbidities presented with nasal blockage, intermittent nasal bleeding, eye pain and headache. There is no family history of malignancies. There was a 2 x 2 cm palpable left level II cervical lymph node. CECT of para-nasal sinuses and CEMRI of orbits showed a large lobulated enhancing mass epicentred in right nasal cavity, with variable extension in right maxillary, ethmoid and sphenoid sinus. There was bony destruction of nasal septum, lateral nasal wall and nasal turbinates. Intracranially extension is seen in basi-frontal region and right side of skull base. Scalloping and erosion of medial wall of right orbit is noted with mass effect on underlying medial rectus muscle and right optic nerve in its intracanalicular and adjacent intracranial part. Biopsy of nasal mass showed features of esthesioneuroblastoma (ENB), Hyams grade II that was immunopositive for chromogranin, INSM1, synaptophysin and focally for NKX2.2 with prominent fibrovascular stroma. However, rosettes, calcification and necrosis was absent. Patient was started on palliative chemotherapy with cisplatin and capecitabine. Subjective and radiological response was present after three cycles with enhancing lesion present in posterior aspect of right nasal cavity extending to bilateral sphenoid sinus and erosion of sinus.
However, after receiving 5 cycles patient developed recurrent episodes of hyponatremia and an episode of generalised seizures. Blood and urine investigations showed - Hb - 12.0g/dL, TLC - 8700/mm3, Platelet - 314x103/mm3, Blood urea- 14mg/dL, serum(S) creatinine-0.7mg/dL, Total bilirubin-0.7mg/dL, S. AST-26U/L, S. ALT-13U/L, S. ALP-97U/L, S. Sodium-106mmol/L, S. Potassium-3.9mmol/L; Urine potassium - 16.06mmoL/L, Urine sodium-121mmol/L, Urine osmolality- 382mosmkg/water.
CEMRI of orbit and PNS was done which showed progressive disease with the mass in nasopharyngeal wall extending into sella region causing erosion of sella and clivus. It was also extending into cavernous sinus, middle cranial fossa and causing erosion of bilateral medial temporal bones and encasing bilateral extraorbital optic nerves. Clinical findings are suggestive of new onset paraneoplastic SIADH associated with progressive ENB.
Clinical trial identification
Editorial acknowledgement
Resources from the same session
399P - Role of denosumab as targeted therapy in treatment of unresectable or recurrent cases of giant cell tumor of the bone
Presenter: Anchal Mishra
Session: Poster viewing 06
400P - Phase I study of fianlimab, a human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced melanoma (mel)
Presenter: Omid Hamid
Session: Poster viewing 06
401P - A phase Ib study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in combination with lenvatinib in patients (pts) with advanced solid tumors
Presenter: Shunsuke Kondo
Session: Poster viewing 06
402P - Phase I study of selumetinib in Chinese pediatric and adult patients (pts) with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN): Interim results
Presenter: Xiao-Jun Yuan
Session: Poster viewing 06
403P - Gender trend over time of principal investigators within large Australian cancer clinical trials groups
Presenter: Thi Thao Vi Luong
Session: Poster viewing 06
404P - Adolescent & young adult cancers (AYA): Experience from a large rural teaching hospital in South India
Presenter: Vishwapriya Godkhindi
Session: Poster viewing 06
405P - Evaluating medical oncology outcomes (EMOO) in Asia study: Diagnosis, staging, treatment patterns and outcome of patients with lung cancer registered 2017-2019
Presenter: Ross Soo
Session: Poster viewing 06
406P - Adrenal insufficiency induced by immune checkpoint inhibitors: Clinical characteristics of 145 cases
Presenter: kaoru koshiba
Session: Poster viewing 06
407P - A post-marketing surveillance of the real-world safety and effectiveness of avelumab in patients with curatively unresectable Merkel cell carcinoma in Japan
Presenter: Naoya Yamazaki
Session: Poster viewing 06
408P - Machine learning for glioblastoma screening from histopathology whole slide imaging
Presenter: Eva Yi Wah Cheung
Session: Poster viewing 06